Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 803015, 9 pages
http://dx.doi.org/10.1155/2011/803015
Research Article

Neuroprotection by the Traditional Chinese Medicine, Tao-Hong-Si-Wu-Tang, against Middle Cerebral Artery Occlusion-Induced Cerebral Ischemia in Rats

1Division of Nephrology, Mackay Memorial Hospital, Taipei 104, Taiwan
2Mackay Medicine, Nursing and Management College, Taipei 112, Taiwan
3Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, 250 Wuxing St., Taiwan
4Department of Anesthesiology, WanFang Hospital, and Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei 110, Taiwan

Received 20 May 2010; Revised 24 August 2010; Accepted 7 October 2010

Copyright © 2011 Chih-Jen Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kuroda and B. K. Siesjö, “Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows,” Clinical Neuroscience, vol. 4, no. 4, pp. 199–212, 1997. View at Google Scholar · View at Scopus
  2. T. Abumiya, R. Fitridge, C. Mazur et al., “Integrin α(IIb)β3 inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia,” Stroke, vol. 31, no. 6, pp. 1402–1410, 2000. View at Google Scholar · View at Scopus
  3. C. Iadecola, F. Zhang, R. Casey, H. B. Clark, and M. E. Ross, “Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia,” Stroke, vol. 27, no. 8, pp. 1373–1380, 1996. View at Google Scholar · View at Scopus
  4. P. H. Chan, “Reactive oxygen radicals in signaling and damage in the ischemic brain,” Journal of Cerebral Blood Flow and Metabolism, vol. 21, no. 1, pp. 2–14, 2001. View at Google Scholar · View at Scopus
  5. P. Lipton, “Ischemic cell death in brain neurons,” Physiological Reviews, vol. 79, no. 4, pp. 1431–1568, 1999. View at Google Scholar · View at Scopus
  6. K.-T. Liou, Y.-C. Shen, C.-F. Chen, C.-M. Tsao, and S.-K. Tsai, “Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production,” Brain Research, vol. 992, no. 2, pp. 159–166, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Shimizu, N. Rajapakse, T. Horiguchi, R. M. Payne, and D. W. Busija, “Protective effect of a new nonpeptidyl mimetic of SOD, M40401, against focal cerebral ischemia in the rat,” Brain Research, vol. 963, no. 1-2, pp. 8–14, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. T. F. Choudhri, B. L. Hoh, H.-G. Zerwes et al., “Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIa receptor-mediated platelet aggregation,” Journal of Clinical Investigation, vol. 102, no. 7, pp. 1301–1310, 1998. View at Google Scholar · View at Scopus
  9. Y. Liu, Y. Ling, W. Hu, L. Xie, L. Yu, and X. Qian, “The herb medicine formula ‘Chong Lou Fu Fang’ increases the cytotoxicity of chemotherapeutic agents and down-regulates the expression of chemotherapeutic agent resistance-related genes in human gastric cancer cells in vitro,” Evidence-Based Complementary and Alternative Medicine. In press. View at Publisher · View at Google Scholar
  10. C. S. Shia, Y. C. Hou, S. H. Juang, S. Y. Tsai, P. H. Hsieh, and L. C. Ho, “Metabolism and pharmacokinetics of San-Huang-Xie-Xin-Tang, a polyphenol-rich Chinese medicine formula, in rats and ex-vivo antioxidant activity,” Evidence-Based Complementary and Alternative Medicine. In press. View at Publisher · View at Google Scholar
  11. X. P. Huang, “Report on essential hypertension (51 cases) treated by differentiation of symptoms and signs,” Journal of Practical Traditional Chinese Medicine, vol. 2, pp. 68–69, 2006. View at Google Scholar
  12. J. M. Yang, “Therapeutic effect observation of 154 cases of coronary artery disease angina using Taohongsiwutang (THSW),” China Journal of Modern Medicine, vol. 17, pp. 2268–2275, 2007. View at Google Scholar
  13. H. Shi and L. Shi, “The clinical effect of modified Taohongsiwu decoction on diabetes peripheral neuropathy,” Journal of Henan University of Chinese Medicine, vol. 21, pp. 38–39, 2006. View at Google Scholar
  14. Z.-X. Qi and C.-B. Du, “Local microcirculation changes in rabbits with glucocorticoid-induced avascular necrosis of femoral head following Taohong Siwu decoction treatment,” Journal of Clinical Rehabilitative Tissue Engineering Research, vol. 12, no. 11, pp. 2104–2107, 2008. View at Google Scholar · View at Scopus
  15. G. Hsiao, K. H. Lin, Y. Chang et al., “Protective mechanisms of inosine in platelet activation and cerebral ischemic damage,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 9, pp. 1998–2004, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. E. J. Lee, H.-Y. Chen, T.-S. Wu, T.-Y. Chen, I. A. Ayoub, and K. I. Maynard, “Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats,” Journal of Neuroscience Research, vol. 68, no. 5, pp. 636–645, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Rodrigo, D. Alonso, A. P. Fernández et al., “Neuronal and inducible nitric oxide synthase expression and protein nitration in rat cerebellum after oxygen and glucose deprivation,” Brain Research, vol. 909, no. 1-2, pp. 20–45, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. J.-R. Sheu, C.-R. Lee, C.-H. Lin et al., “Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets,” Thrombosis and Haemostasis, vol. 83, no. 5, pp. 777–784, 2000. View at Google Scholar · View at Scopus
  19. G. Hsiao, J.-J. Lee, Y.-C. Chen et al., “Neuroprotective effects of PMC, a potent α-tocopherol derivative, in brain ischemia-reperfusion: reduced neutrophil activation and anti-oxidant actions,” Biochemical Pharmacology, vol. 73, no. 5, pp. 682–693, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. D. Ginsberg and R. Busto, “Rodent models of cerebral ischemia,” Stroke, vol. 20, no. 12, pp. 1627–1642, 1989. View at Google Scholar · View at Scopus
  21. C. M. Wiener, G. Booth, and G. L. Semenza, “In vivo expression of mRNAs encoding hypoxia-inducible factor 1,” Biochemical and Biophysical Research Communications, vol. 225, no. 2, pp. 485–488, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Melillo, T. Musso, A. Sica, L. S. Taylor, G. W. Cox, and L. Varesio, “A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter,” Journal of Experimental Medicine, vol. 182, no. 6, pp. 1683–1693, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. Moro, J. De Alba, J. C. Leza et al., “Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices,” European Journal of Neuroscience, vol. 10, no. 2, pp. 445–456, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Iadecola, F. Zhang, R. Casey, M. Nagayama, and M. Elizabeth Ross, “Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene,” Journal of Neuroscience, vol. 17, no. 23, pp. 9157–9164, 1997. View at Google Scholar · View at Scopus
  25. M. E. Gibson, H. H. Byung, J. Choi et al., “BAX contributes to apoptotic-like death following neonatal hypoxia-ischemia: evidence for distinct apoptosis pathways,” Molecular Medicine, vol. 7, no. 9, pp. 644–655, 2001. View at Google Scholar · View at Scopus
  26. H. Suzuki, A. Tomida, and T. Tsuruo, “Dephosphorylated hypoxia-inducible factor 1α as a mediator of p53-dependent apoptosis during hypoxia,” Oncogene, vol. 20, no. 41, pp. 5779–5788, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. F. C. Barone, B. Arvin, R. F. White et al., “Tumor necrosis factor-α: a mediator of focal ischemic brain injury,” Stroke, vol. 28, no. 6, pp. 1233–1244, 1997. View at Google Scholar · View at Scopus
  28. S. Gupta, “Molecular steps of tumor necrosis factor receptor-mediated apoptosis,” Current Molecular Medicine, vol. 1, no. 3, pp. 317–324, 2001. View at Google Scholar · View at Scopus
  29. J.-R. Sheu, W.-C. Hung, C.-H. Wu et al., “Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia,” Circulation, vol. 99, no. 23, pp. 3056–3062, 1999. View at Google Scholar · View at Scopus
  30. J.-R. Sheu, S.-H. Chao, M.-H. Yen, and T.-F. Huang, “In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice,” Thrombosis and Haemostasis, vol. 72, no. 4, pp. 617–621, 1994. View at Google Scholar · View at Scopus